Table 2.
Correlation analysis for miRNA-21 and miRNA-499.
| Characteristic | miRNA-21 | miRNA-499 | ||
|---|---|---|---|---|
| qRT-PCR | Chip-based digital PCR | qRT-PCR | Chip-based digital PCR | |
| Age | P=0.5259 | P=0.2925 | P=0.4583 | P=0.1686 |
| DM | P=0.4186 | P=0.2331 | P=0.6590 | P=0.9482 |
| Smoking | P=0.3888 | P=0.4722 | P=0.4981 | P=0.5758 |
| Aspirin | P=0.6604 | P=0.3315 | P=0.2368 | P=0.2205 |
| Clopidogrel | P=0.5949 | P=0.9036 | P=0.0566 | P=0.0966 |
| Prasugrel | P=0.0947 | P=0.4382 | P=0.0045 | P=0.0073 |
| Ticagrelor | P=0.4132 | P=0.4364 | P=0.1547 | P=0.5186 |
| Eptifibatide | P=0.5161 | P=0.5768 | P=0.0933 | P=0.0012 |
| Rivaroxaban | P=0.1663 | P=0.3014 | P=0.6577 | P=0.6067 |
| Statin | P=0.4476 | P=0.5391 | P=0.5789 | P=0.8316 |
| Creatinine | P=0.5248 | P=0.0429 | P=0.6878 | P=0.6690 |
| CK | P=0.0045 | P=0.0367 | P<0.0001 | P=0.0027 |
| cTnT | P=0.0471 | P=0.1801 | P=0.0803 | P=0.2136 |
| CK-MB | P=0.0071 | P=0.0800 | P=0.2151 | P=0.0004 |
| CRP | P=0.0580 | P=0.7150 | P=0.8451 | P=0.3048 |
| LVEF% | P=0.4348 | P=0.5248 | P=0.1492 | P=0.9088 |
| Time blood taken for miRNA analysis after PCI (h) | P=0.5272 | P=0.6715 | P=0.0142 | P=0.8285 |
DM: Diabetes mellitus; CK: Creatine kinase; cTnT: Cardiac troponin T; CK-MB: Creatine kinase myocardial-band; CRP: C-reactive protein; LVEF%: Left ventricular ejection fraction (%); PCI: Percutaneous coronary intervention.